Dr. Buechler joined Ambrx as Vice President of Development. In this role, she is responsible for protein therapeutics process development and manufacturing. Previously, she was Executive Director of Biologics Development and Manufacturing at aTyr Pharma, where she led the team comprising upstream and downstream process development, analytical and formulation development functions for more than 7 years, including the successful execution of development and manufacturing activities for multiple clinical programs. Dr. Buechler was an employee of Ambrx from December 2003 to November 2010 and served as director of process development and characterization, where she led protein purification and conjugation process development, and analytics and formulations teams, led interactions with contract manufacturing organizations, and served as a project leader. Prior to that, she worked for EGen Corporation, Prizm Pharmaceuticals, and Canji, with increasing scientific and managerial responsibilities. Dr. Buechler received her Ph.D. in Chemistry from University of California, San Diego, and B.S. from Peking University.